...
首页> 外文期刊>Chemical research in toxicology >Mass spectrometric characterization of modifications to angiotensin II by lipid peroxidation products, 4-oxo-2(E)-nonenal and 4-hydroxy-2(E)-nonenal.
【24h】

Mass spectrometric characterization of modifications to angiotensin II by lipid peroxidation products, 4-oxo-2(E)-nonenal and 4-hydroxy-2(E)-nonenal.

机译:脂质过氧化产物4-oxo-2(E)-壬烯醛和4-羟基-2(E)-壬烯醛对血管紧张素II修饰的质谱表征。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The octapeptide angiotensin II (Ang II; Asp(1)-Arg(2)-Val(3)-Tyr(4)-Ile(5)-His(6)-Pro(7)-Phe(8)) is the primary active hormone of the renin/angiotensin system (RAS) and has been implicated in various cardiovascular diseases. Numerous structure-activity relationship studies have identified Asp(1), Arg(2), and His(6) of Ang II to be critical for its biological activity and receptor binding. From the reactions of Ang II with lipid peroxidation-derived aldehydes, 4-oxo-2(E)-nonenal (ONE) or 4-hydroxy-2(E)-nonenal (HNE), we have identified the major modifications to the N-terminus, Asp(1), Arg(2), and His(6) of Ang II by liquid chromatography/mass spectrometry (LC/MS) and matrix-assisted laser desorption ionization-time-of-flight/MS (MALDI-TOF/MS). The identities of ONE- and HNE-modified Ang II were confirmed by tandem mass spectrometry (MS/MS) and postsource decay (PSD)-TOF/MS before and after the reaction with sodium borohydride. In the reaction with ONE, a pyruvamide-Ang II that formed via oxidative decarboxylation of N-terminal Asp was detected as the most abundant product after 48 h of incubation. It was followed by Arg-modified [Arg(2)(ONE-H(2)O)]-Ang II and the N-terminal-modified 4-ketoamide form of [N-ONE]-Ang II. The Michael addition products of [His(6)(HNE)]-Ang II were the most abundant products in the beginning of the reaction with HNE, followed by the dehydrated Michael addition products of [His(6)(HNE-H(2)O)]-Ang II. [His(6)(HNE)]-Ang II was dehydrated to [His(6)(HNE-H(2)O)]-Ang II during the prolonged incubation, and [His(6)(HNE-H(2)O)]-Ang II became the major products after 7 days. The model reactions of N(alpha)-tert-butoxycarbonyl (tBoc)-Arg with ONE and tBoc-His with HNE were performed and compared with the Ang II reaction. tBoc-Arg readily reacted with ONE to produce a compound analogous to [Arg(2)(ONE-H(2)O)]-Ang II, which confirmed Arg as one of the important target nucleophiles of ONE. However, tBoc-His exclusively formed a Michael addition product upon the reaction with HNE. The unexpected formation of [His(6)(HNE-H(2)O)]-Ang II can be explained by the proximity of His(6) to C-terminal carboxylate in the specific conformation of Ang II, which facilitates the dehydration of Michael addition products. Therefore, our results suggest a possible discrepancy in the adduction chemistry of ONE and HNE for model amino acids and endogenous bioactive peptides, which is governed by the microenvironment of peptides, such as the specific amino acid sequence and conformation. Such stable ONE- and HNE-derived modifications to Ang II could potentially modulate its functions in vivo by disrupting the interaction with Ang II type 1 (AT(1)) receptor and/or inhibiting the enzyme activity of aminopeptidase A (APA), which cleaves the N-terminal Asp residue of Ang II to generate Ang III.
机译:八肽血管紧张素II(Ang II; Asp(1)-Arg(2)-Val(3)-Tyr(4)-Ile(5)-His(6)-Pro(7)-Phe(8)是肾素/血管紧张素系统(RAS)的主要活性激素,并与多种心血管疾病有关。大量的构效关系研究已经确定了Ang II的Asp(1),Arg(2)和His(6)对于其生物学活性和受体结合至关重要。从Ang II与脂质过氧化衍生的醛,4-oxo-2(E)-壬烯醛(ONE)或4-羟基-2(E)-壬烯醛(HNE)的反应中,我们确定了N的主要修饰液相色谱/质谱(LC / MS)和基质辅助激光解吸电离飞行时间/ MS(MALDI-)检测到的Ang II的末端,Asp(1),Arg(2)和His(6) TOF / MS)。在与硼氢化钠反应之前和之后,通过串联质谱(MS / MS)和源后衰减(PSD)-TOF / MS确认了ONE和HNE修饰的Ang II的身份。在与ONE的反应中,孵育48小时后,通过N末端Asp的氧化脱羧形成的丙酮酰胺-Ang II被检测为最丰富的产物。其后是Arg修饰的[Arg(2)(ONE-H(2)O)]-Ang II和[N-ONE] -Ang II的N-末端修饰的4-酮酰胺形式。 [His(6)(HNE)]-Ang II的迈克尔加成产物是与HNE反应开始时最丰富的产物,其次是[His(6)(HNE-H(2) )O)]-Ang II。 [His(6)(HNE)]-Ang II在长时间孵育过程中脱水成[His(6)(HNE-H(2)O)]-Ang II,而[His(6)(HNE-H(2) )O)]-Ang II在7天后成为主要产品。进行了带有ONE的Nα-叔丁氧羰基(tBoc)-Arg和带有HNE的tBoc-His的模型反应,并与Ang II反应进行了比较。 tBoc-Arg易于与ONE反应生成类似于[Arg(2)(ONE-H(2)O)]-Ang II的化合物,该化合物证实Arg是ONE的重要靶亲核试剂之一。但是,tBoc-His与HNE反应后仅形成迈克尔加成产物。 [His(6)(HNE-H(2)O)]-Ang II的意外形成可以通过在Ang II的特定构象中His(6)与C末端羧酸盐的接近来解释,这有助于脱水迈克尔的附加产品。因此,我们的结果表明,模型氨基酸和内源性生物活性肽在ONE和HNE的加成化学中可能存在差异,这取决于肽的微环境,例如特定的氨基酸序列和构象。对Ang II的这种稳定的ONE和HNE衍生修饰可能通过破坏与Ang II 1型(AT(1))受体的相互作用和/或抑制氨肽酶A(APA)的酶活性来潜在地调节其体内功能。切割Ang II的N-末端Asp残基以产生Ang III。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号